ASHEVILLE EYE ASSOCIATES PLLC
NPI: 1295799823
· ASHEVILLE, NC 28803
· 156FX1101X
$6.35M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
| 2018 |
32,766 |
$758K |
| 2019 |
27,563 |
$841K |
| 2020 |
25,254 |
$809K |
| 2021 |
31,126 |
$916K |
| 2022 |
28,855 |
$935K |
| 2023 |
33,260 |
$1.06M |
| 2024 |
30,099 |
$1.03M |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
| S0621 |
Routine ophthalmological exa |
25,784 |
19,117 |
$1.61M |
| S0620 |
Routine ophthalmological exa |
14,225 |
10,254 |
$1.04M |
| 92340 |
|
39,107 |
29,737 |
$617K |
| 92060 |
|
18,991 |
13,575 |
$579K |
| 99213 |
|
13,877 |
9,683 |
$487K |
| 92014 |
|
14,586 |
10,537 |
$422K |
| 99214 |
|
7,673 |
5,329 |
$341K |
| 67028 |
|
8,847 |
4,772 |
$244K |
| 92370 |
|
37,278 |
29,523 |
$202K |
| 99243 |
|
1,814 |
1,474 |
$147K |
| 99244 |
|
1,349 |
747 |
$107K |
| J0178 |
Aflibercept injection |
259 |
103 |
$86K |
| 99204 |
|
1,164 |
833 |
$81K |
| 92015 |
|
6,117 |
4,518 |
$71K |
| 99203 |
|
1,239 |
944 |
$66K |
| 92134 |
|
9,506 |
5,899 |
$56K |
| J2778 |
Ranibizumab injection |
273 |
115 |
$56K |
| 92012 |
|
1,327 |
1,032 |
$41K |
| J9035 |
Bevacizumab injection |
1,701 |
855 |
$22K |
| 92004 |
|
346 |
286 |
$21K |
| 99211 |
|
1,292 |
996 |
$16K |
| J2777 |
Inj, faricimab-svoa, 0.1mg |
51 |
24 |
$12K |
| 92250 |
|
597 |
411 |
$10K |
| 92083 |
|
468 |
260 |
$8K |
| 66984 |
|
86 |
38 |
$3K |
| 92341 |
|
153 |
119 |
$3K |
| 92136 |
|
231 |
137 |
$2K |
| 92133 |
|
138 |
103 |
$2K |
| 99212 |
|
57 |
38 |
$1K |
| 99233 |
Prolong inpt eval add15 m |
53 |
12 |
$1K |
| 99058 |
|
55 |
42 |
$466.23 |
| 92020 |
|
16 |
13 |
$115.32 |
| 92285 |
|
55 |
41 |
$90.57 |
| 92201 |
|
208 |
114 |
$0.00 |